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Background: The impact of improved nutritional status on health-related quality of life (HRQOL) is unknown for children with cystic ﬁbrosis
(CF).
Methods: Associations between nutritional status and HRQOL were examined over 2 years in 95 children, aged 9–19 years, who were followed
in the Wisconsin Newborn Screening Project. HRQOL was assessed using the Cystic Fibrosis Questionnaire (CFQ). Associations between height
z-score (HtZ), BMI z-score (BMIZ) and seven CFQ dimensions were evaluated.
Results: Mean values of at least 80 were observed for all CFQ dimensions except respiratory symptoms and treatment burden. Treatment burden
was signiﬁcantly worse in patients with meconium ileus (57) compared to pancreatic insufﬁcient (65) and sufﬁcient (78) subjects, pb0.0001. HtZ
and BMIZ were positively associated with physical functioning and body image (pb0.05).
Conclusions: Better nutritional status was associated with increased HRQOL scores. Early diagnosis through newborn screening and improved
nutrition provides an opportunity to enhance quality of life and body image perception.
© 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: cystic ﬁbrosis; quality of life; nutrition1. Background
Achieving optimal growth and maintaining adequate nutri-
tional status are cornerstones of clinical care in cystic fibrosis
(CF). Indeed, in recent years there has been an increased focus on
nutritional management with early intervention [1,2]. Although
achieving optimal growth is important and is significantly
associated with pulmonary health [3,4], the impact of achieving
nutritional goals on improving pediatric patients’ perceptions of
well-being is largely unknown.⁎ Corresponding author at: University ofWisconsin-Madison,Madison,WI, USA
53726. Tel.: +1 608 263 9094; fax: +1 608 262 2820.
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http://dx.doi.org/10.1016/j.jcf.2013.01.006Investigations of patient-reported outcomes in people with CF,
such as health-related quality of life (HRQOL), and functional
measures of health [5–17] have primarily focused on respiratory
well-being and pulmonary function tests as endpoints in drug
trials [11–17], although other reports have had a broader scope
[5–10]. Overall, pulmonary measures are consistently associated
with self-reported respiratory health. Few studies [6,9], and only
one in children [9], have evaluated nutritional status andHRQOL.
These sparse data suggest that weight status is important for
supporting both physical dimensions of HRQOL (respiratory and
physical) and those related to nutritional issues (body image,
eating disturbances). However, to our knowledge, there are no
published reports on multiple indicators nutritional status, such
as stature, and HRQOL in children with CF who experienced
early diagnosis. Thus, the objective of this study is to examineby Elsevier B.V. All rights reserved.
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in children and adolescents with CF.
2. Subjects and methods
2.1. Study population
The study population consists of children and adolescents
who were enrolled in the Wisconsin Randomized Clinical Trial
(RCT) of CF Newborn Screening (NBS). TheWisconsin RCT is
a prospective longitudinal investigation [18,19], designed to
assess the benefits and risks of newborn screening for CF. It
enrolled 138 infants with CF from 1985 to 1998 and included
quarterly visits through 2011. In 2002–2006, an ancillary study
was conducted to evaluate psychosocial outcomes. The current
study is composed of subjects aged 9–19 years (N=95) who
agreed to participate in the ancillary study and complete
psychosocial assessments. Included in these assessments was
the administration of a HRQOL questionnaire (described below).
The study was approved by Institutional Review Boards of the
two participating CF centers, and informed consent was obtained
prior to participation.
2.2. Assessment of health-related quality of life
The Cystic Fibrosis Questionnaire (CFQ) [20–22] was ad-
ministered yearly during three regularly scheduled routine clinic
visits. The CFQ assesses multiple dimensions of HRQOL in
patients with CF. By design, it was interviewer-administered
to 6–11 year olds (8 dimensions, ‘child’ questionnaire, N=31
at first CFQ administration) and self-administered by 12–13 (8
dimensions, ‘child’ questionnaire, N=23 at first CFQ adminis-
tration) and≥14 year olds (12 dimensions, ‘adolescent’ ques-
tionnaire, N=41 at first CFQ administration). Eight dimensions
are common to the child and adolescent questionnaire versions,
but the dimension “digestive symptoms” had only one question to
assess it in the child version, and was not included. The remaining
seven dimensions were evaluated: physical functioning, respira-
tory symptoms, social functioning, emotional functioning, treat-
ment burden, body image and eating disturbances. Scores for
each dimension are standardized to a 0–100 point scale, with 100
representing the most favorable HRQOL.
2.3. Categorization of CFQ dimensions
Scores were categorized to minimize the imbalance caused by
ceiling effects, which have been reported by others [20,22].
Categories were also established to assign meaning to the value
of the scores. Categories of scores were defined as follows:
“Mostly Low” are scores b66.0, which correspond to a com-
bination of the two least favorable responses to questions in a
CFQ dimension (e.g. ‘never’ and ‘sometimes’ for frequency
responses). Because only two subjects ever gave the lowest
response for all questions representing a given dimension, a
‘worst’ category could not be assigned. “Mostly Good” is a score
between 66.0-99.9 which corresponds to a combination of the
two most favorable responses to questions in a CFQ dimension(e.g. ‘often’ or ‘always’ for frequency responses); “Perfect” is a
score equal to 100 which corresponds to all responses for all
questions in a given dimension equal to the most favorable
response (e.g. ‘always’ for frequency responses). The validity of
these categorizations has not been formally evaluated in inde-
pendent studies.
2.4. CF pancreatic phenotype and nutritional status
Pancreatic function was primarily determined by 72-hour
fecal fat at approximately 4 years of age [19]. Pancreatic status
phenotype was defined according to the presence of meconium
ileus (MI), pancreatic insufficiency (PI) without MI, and pan-
creatic sufficiency (PS).
Nutritional status was represented by multiple indices of
growth, including height and bodymass index (BMI). Height and
weight were measured concurrently at the time of CFQ ad-
ministration, as part of routine clinical examinations. BMI was
calculated [weight in kilograms/(height in meters) 2]. Age- and
gender-specific z-scores and percentiles for BMI (BMIZ and
BMIP, respectively), weight (WtZ and WtP, respectively), and
height (HtZ and HtP, respectively) were computed by using the
2000 Centers for Disease Control's growth reference (www.cdc.
gov/growthcharts) [23].
Nutritional status was classified using both BMIP and HtP
according to the following cut-points [24,25]: short stature was
defined as HtP b5th percentile and underweight was defined as
BMIP b10th percentile. ‘Below BMI goal’ was defined by a
BMIP b50th percentile [2].
2.5. Statistical analysis
The dataset is composed of 265 observations from 95
participants. Data analysis was performed using SAS statistical
software (version 9.2; SAS Institute Inc, Cary, NC). Simple
summary statistics were computed at each CFQ administration
time point (CFQ-1, CFQ-2, CFQ-3). When data are not presented
by CFQ time point, all observations were utilized. Chi-square or
Fisher Exact Test was used to test for differences in proportions
and Cochran–Mantel–Haenszel (CMH) statistics were used
when adjusting for other factors.
For longitudinal analysis, generalized estimating equation
(GEE) methods with repeated measures were used to examine
associations between continuous dimension scores (each dimen-
sion as a separate outcome variable) and continuous growth
indicators (BMIZ and HtZ), while accounting for CFQ version
(child or adolescent version), age, gender, pancreatic function
phenotype and mode of diagnosis (screened or conventional
diagnosis). HtZ and BMIZ were included in models together in
order to account for both stature and relative weight status. Re-
gression analyses involving continuous height and BMI utilized
z-score values, but percentile results are presented because the
latter are displayed on the CDC growth charts and are commonly
used in the clinical setting.
In order to minimize the influence of the ceiling effect in the
CFQ dimension scores, logistic regression using GEE was also
employed. For these models, dichotomous dimension variables
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Mostly Good scores and Perfect scores) were constructed in
order to compute the odds of Mostly Low scores for categorical
levels of nutritional status indicators (i.e., indicators of short
stature, underweight, and below BMI goal). The dichotomous
nutritional status indicators, short stature and underweight,
were included simultaneously, and all models also included
CFQ version, age, gender, phenotype and mode of diagnosis.
3. Results
3.1. Subject characteristics at each CFQ administration
Mean age at first CFQ was 13.5 years (Table 1). Nutritional
status, represented by weight, height and BMI percentiles (43±30,
42±29 and 48±26, respectively, at first CFQ), was stable over the
2-year study period (pN0.1 for change over the three time points).
On average, over the three time points, 12% of subjects had short
stature, 8% were underweight, and 53% were below the BMI goal
of being at the 50th percentile recommended by current CFF
guidelines [2]. Very few (≤ 2 subjects) exhibited both short stature
and underweight.
3.2. CFQ dimension scores at each time point
Table 1 also displays the mean of each of the 7 CFQ dimen-
sions at each time point, as well as the overall mean score.
Dimension scores were typically high, with mean scores of at
least 80 observed for eating disturbances, physical functioning,Table 1
Nutritional status and CFQ dimension scores at each CFQ. ⁎
CFQ-1 CFQ-2 CFQ-3 Overall ⁎⁎
N 94 91 80
Age (years), mean±SD 13.5±2.8 14.5±2.8 15.5±2.8 –
Nutritional Status
Weight percentile, mean±SD 43±30 46±29 45±28 44±29
Height percentile, mean±SD 42±30 42±30 42±30 42±29
BMI percentile, mean±SD 47±28 51±28 50±26 48±26
Short stature † [N (%)] 12 (13%) 10 (11%) 10 (13%) 12%
Underweight † [N (%)] 9 (10%) 8 (9%) 5 (6%) 8%
Short and underweight † [N (%)] 1 (1%) 2 (2%) 0 1%
Below BMI goal † [N (%)] 53 (56%) 46 (51%) 41 (52%) 53%
CFQ Dimensions (mean±SD)
Eating disturbances 88±19 91±16 92±16 90±13
Physical functioning 84±18 85±18 88±16 85±16
Emotional functioning 82±16 83±14 84±15 83±13
Body image 81±25 81±24 82±23 82±21
Social functioning 80±14 81±16 81±16 81±13
Respiratory symptoms 77±18 78±16 79±14 77±14
Treatment burden ‡ 63±19 68±21 65±18 65±15
⁎ For assessing change over time, nutritional status GEE models (WtZ, HtZ
and BMIZ) controlled for age, sex and mode of diagnosis; for CFQ dimensions,
GEE models controlled for age, sex, mode of diagnosis and CFQ version.
⁎⁎ Overall mean values represent the average of means from each subject.
† Nutritional status indicators are defined as follows: short stature is height
b5th percentile; underweight is BMI b10th percentile; below BMI goal is BMI
b50th percentile.
‡ p=0.045.emotional functioning, body image, and social functioning.
Respiratory symptoms and treatment burden had the lowest scores
indicating more frequent issues with pulmonary health and the
intrusion of medical therapy in daily activities. In general, CFQ
scores did not change appreciably over the 2 years of observa-
tions, i.e., there were no trends discernible in the longitudinal data.
3.3. Nutritional status and QOL dimension scores according to
phenotype
Nutritional status indicators, CFQ dimension scores, and
distribution of score categories, according to pancreatic function
phenotype, are shown in Table 2. PI was present in 63% of
subjects (N=59), while 21% (n=20) and 16% (n=15) of subjects
had MI and PS, respectively. Mean HtP was highest in PS
subjects (60±19), followed by PI (43±30) and MI (27±27), p=
0.002. BMIP did not differ significantly among the 3 groups (p=
0.21), though a similar pattern to HtP was observed.
Average QOL dimension score was borderline significantly
different for physical functioning (p=0.08) with lowest scores
(78±18) observed in MI subjects compared to PI (87±15) and
PS (88±14). MI subjects had significantly greater prevalence
of Mostly Low scores (score b66) for physical functioning (25%
compared to 9% in PI and 7% in PS, p=0.04). Similarly, low
scores for respiratory symptoms were more prevalent among MI
subjects (32%) compared to PI (13%) and PS (12%), p=0.03.
Scores for treatment burden differed significantly, with the
highest observed in PS subjects (78±14), followed by PI (65±
14) and MI (57±16), p=0.002. Mostly Low scores for treatment
burden were approximately 6 times more prevalent in MI (59%)
compared to PS (10%) subjects, with a prevalence of 42% in PI,
pb0.0001. No significant CFQ dimension score differences were
observed among MI, PI and PS for eating disturbances, body
image, emotional functioning and social functioning.
3.4. CFQ dimension scores according to nutritional status
Fig. 1 shows mean CFQ dimension scores according to HtP
and BMIP. p-Values are from GEE models where both the CFQ
dimension scores and nutritional status indicators (HtZ and BMIZ)
are continuous variables. HtZ (p=0.07) and BMIZ (p=0.09)
exhibited a borderline positive association with eating distur-
bances and no association with emotional functioning, social
functioning, respiratory symptoms or treatment burden. However,
HtZ and BMIZ were positively associated with physical func-
tioning (p=0.02 and p=0.02, respectively) and body image (p=
0.02 and p=0.02, respectively). A threshold effect appeared
evident for HtP in that the lowest physical functioning and body
image scores were observed for HtP less than the 10th percentile,
with an approximately 20 point increase that leveled off for HtP
greater than the 10th percentile. BMIP showed less pronounced
differences, but somewhat more linear relationship with physical
functioning and body image. Scores were approximately 10 points
lower for BMIP less than the 25th percentile compared to higher
BMIP categories. Large standard deviations indicate that there was
high variability in dimension scores, particularly at the low end of
nutritional status. Associations withWtZ followed patterns similar
Table 2
Nutritional status and CFQ scores according to phenotype. ⁎
Meconium ileus Pancreatic insufficient Pancreatic sufficient Overall p-value
No. subjects (No. observations) 21 (59) 59 (163) 15 (43)
Height percentile, mean±SD 27±27a 43±30b 60±19c 0.002 †
BMI percentile, mean±SD 42±20 48±26 60±31 0.21 †
Eating disturbances, mean±SD 89±15 90±13 92±10 0.68 †
Score distribution [n (%)] 0.71 ‡
Mostly low (b66) 5 (9%) 15 (9%) 3 (7%)
Mostly good (66–99) 20 (34%) 48 (29%) 12 (28%)
Perfect (100) 33 (57%) 100 (61%) 28 (65%)
Physical functioning, mean±SD 78±18 87±15 88±14 0.08 †
Score distribution [n (%)] 0.04 ‡
Mostly low (b66) 15 (25%) 15(9%) 3 (7%)
MostlygGood (66–99) 25 (42%) 82 (50%) 24 (56%)
Perfect (100) 19 (32%) 66 (40%) 16 (37%)
Emotional functioning, mean±SD 81±14 83±13 84±10 0.42 †
Score distribution [n (%)] 0.70 ‡
Mostly Low (b66) 11 (19%) 21 (13%) 2 (5%)
Mostly Good (66–99) 34 (58%) 107 (66%) 36 (84%)
Perfect (100) 14 (24%) 35 (21%) 5 (11%)
Body image, mean±SD 80±27 83±19 82±20 0.87 †
Score distribution [n (%)] 0.99 ‡
Mostly Low (b66) 13 (22%) 27 (17%) 9 (21%)
Mostly Good (66–99) 18 (31%) 66 (40%) 15 (35%)
Perfect (100) 27 (47%) 70 (43%) 19 (44%)
Social functioning, mean±SD 80±14 80±13 87±9 0.20 †
Score distribution [n (%)] 0.46 ‡
Mostly Low (b66) 13 (22%) 30 (18%) 2 (5%)
Mostly Good (66–99) 33 (57%) 107 (66%) 34 (79%)
Perfect (100) 12 (21%) 26 (16%) 7 (16%)
Respiratory symptoms, mean±SD 71±18 78±12 82±12 0.13 †
Score distribution [n (%)] 0.03 ‡
Mostly Low (b66) 19 (32%) 21 (13%) 5 (12%)
Mostly Good (66–99) 35 (59%) 132 (81%) 33 (77%)
Perfect (100) 5 (8%) 10 (6%) 5 (12%)
Treatment burden, mean±SD 57±16a 65±14b 78±14c 0.002 †
Score distribution [n (%)] b0.0001 ‡
Mostly Low (b66) 34 (59%) 69 (42%) 4 (10%)
Mostly Good (66–99) 21 (36%) 86 (53%) 26 (63%)
Perfect (100) 3 (5%) 8 (5%) 11 (27%)
a, b, cvalues with different superscripts within the same row were statistically different.
⁎ mean values represent average of mean scores from each subject.
† Continuous outcomes: for WtZ, HtZ and BMIZ, GEE models also included age, sex and mode of diagnosis; for domain scores, the GEE models included CFQ
version (child or adolescent), age, sex and mode of diagnosis.
‡ Categorical outcomes: CMH models utilized all observations and accounted for CFQ version and age.
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and positively associated with physical functioning (p=0.02) and
body image (p=0.009), and showed a positive, borderline sig-
nificance with eating disturbances (p=0.054).
Fig. 2 shows CFQ dimension scores according to nutritional
status separately in boys and girls. Although there were no gender
differences in mean CFQ dimension scores (data not presented),
three dimensions showed gender-specific associations with nutri-
tional status: eating disturbances, physical functioning and body
image. HtZ (p=0.008) showed a positive association with eating
disturbances in girls only, and the association was borderline
significant with BMIZ (p=0.08) in girls. Similarly, positive
associations between physical functioning and HtZ (p=0.004)
and BMIZ (p=0.04) were observed in girls, but not boys. In girls,
physical functioning was low (b60) in the lowest category of
HtP, and increased incrementally until reaching 100 in thehighest HtP group. Body image was positively associated with
HtZ (p=0.03) and BMIZ (borderline p=0.06) in boys, but not
girls. The HtP threshold effect observed for body image with all
subjects (Fig. 1) was more pronounced in boys (Fig. 2).
3.5. Odds of Mostly Low CFQ dimension scores according to
nutritional status characteristics
Odds ratios of selected Mostly Low CFQ dimension scores
(b66) according to nutritional status are shown in Table 3. Short
stature was associated with a greater odds of Mostly Low scores
for eating disturbances (OR=4.08, 95% CI=1.20–13.79, p=
0.02). Underweight was not associated with any CFQ dimension.
Below BMI goal was associated with an increased odds of



































Eating Disturbances Physical Functioning Emotional Functioning Body Image
Social Functioning Respiratory Symptoms Treatment Burden
HTP   p=0.07
BMIP p=0.09
HTP   p=0.02
BMIP p=0.02
HTP   p=0.73
BMIP p=0.71
HTP    p=0.80
BMIP p=0.66
HTP   p=0.19
BMIP p=0.15
Percentiles
HTP   p=0.02
BMIP p=0.02
HTP   p=0.62
BMIP p=0.67
Fig. 1. Mean quality of life scores according to height and BMI percentiles. P-values are from separate GEE models whereby the outcome (CFQ dimension) and
nutritional status indicators (HtZ, BMIZ) are continuous variables. Covariates included version of CFQ, age, sex, phenotype and mode of diagnosis.
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To our knowledge, this is the first report to describe asso-



































HTP   p=0.57
BMIP p=0.27
HTP   p=0.008
BMIP p=0.08
HTP    p=0.03
BMIP p=0.06






Fig. 2. Mean quality of life scores according to height and BMI percentiles in boys (
outcome (CFQ dimension) and nutritional status indicators (HtZ, BMIZ) are continu
diagnosis. Only the CFQ dimension scores that showed a different association withHRQOL as assessed by the CFQ, particularly in CF patients who
experienced early diagnosis and aggressive nutritional manage-
ment. In this population of older children and adolescents, nu-
tritional status had a measurable impact on self-assessments ofPercentiles
Physical Functioning
HTP   p=0.63
BMIP p=0.19
Percentiles




N=54) and girls (N =41). p-Values are from separate GEE models whereby the
ous variables. Covariates included version of CFQ, age, phenotype and mode of
nutritional status between boys and girls are presented.
Table 3
Odds ratios (95% confidence intervals) of selected Mostly Low CFQ dimension scores according to nutritional status characteristics. ⁎


















No [N (%)] 16 (7%) 215 (93%) 19 (8%) 213 (92%) 43 (18%) 198 (82%) 34 (15%) 198 (85%)
Yes [N (%)] 7 (22%) 25 (78%) 14 (44%) 18 (56%) 6 (27%) 16 (73%) 11 (34%) 21 (66%)
OR (95% CI) (‘yes’ versus ‘no’) 4.08 (1.20, 13.79) † 3.59 (0.81, 15.94) 2.31 (0.62, 8.57) 1.40 (0.60, 3.28)
Underweight ⁎⁎
No [N (%)] 21 (9%) 220 (91%) 29 (12%) 213 (88%) 43 (18%) 198 (82%) 40 (17%) 202 (83%)
Yes [N (%)] 2 (9%) 20 (91%) 4 (18%) 18 (82%) 6 (27%) 16 (73%) 5 (23%) 17 (77%)
OR (95% CI) (‘yes’ versus ‘no’) 5.12 (0.82, 31.82) 1.46 (0.22, 9.73) 1.15 (0.37, 3.58) 1.93 (0.53, 7.11)
Below BMI goal ⁎⁎
No [N (%)] 11 (9%) 112 (91%) 10 (8%) 114 (92%) 12 (10%) 111 (90%) 15 (12%) 109 (88%)
Yes [N (%)] 12 (9%) 128 (91%) 23 (16%) 117 (84%) 37 (26%) 103 (74%) 30 (21%) 110 (79%)
OR (95% CI) (‘yes’ versus ‘no’) 0.74 (0.28, 1.93) 1.69 (0.68, 4.20) 2.67 (1.19, 6.01) † 1.98 (0.74, 5.33)
⁎ Separate model for each CFQ dimension. Covariates: version of CFQ, age, sex, phenotype, and mode of diagnosis. Short stature and underweight in models
simultaneously.
⁎⁎ Short stature is heightb5th percentile; Underweight is BMIb10th percentile; Below BMI goal is BMI b50th percentile.
† pb0.05.
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2 years. Results provide strong evidence that achieving optimal
growth over the short-term (i.e., BMI) and long-term (i.e., stature)
is beneficial for HRQOL. Nutritional status was not significantly
associated with emotional functioning, social functioning, respi-
ratory symptoms and treatment burden indicating that not all
aspects of HRQOL respond to long-term nutrition intervention,
particularly those of the emotional and social domains. Given the
association between nutrition and pulmonary outcome measures
[3,4], and our previously reported association between objective
lung disease surrogates and CFQ respiratory health [5], it is
notable that the qualitative aspects of pulmonary health were not
related to nutritional status. On the other hand, treatment burden
was strongly associated with pancreatic status phenotype.
There were no significant gender differences in mean CFQ
dimension scores or in nutritional status indicators (data not
presented), but it is noteworthy that the strength of associations
between nutritional status and CFQ differed between boys and
girls for some dimensions. The differences between girls and
boys were most striking in those who were short, particularly
for physical functioning in girls and body image in boys.
Additionally, BMI was important for physical functioning in
girls only. These gender-specific results provide insight into which
domains are more closely related to nutritional status in girls and
boys.
The CFQ dimension scores reported here are generally similar
to others [9,20]. Recently, Quittner et al. [26] provided normative
values of CFQ dimension scores for the revised version of the
CFQ, which reports values according to well and sick visits,
pulmonary disease severity and gender. This is an important
resource andwill provide needed reference data. Analyzing results
separately for the child and adolescent CFQ instruments and
relying on weight for age as the nutritional status indicator,
Sawicki et al. [9] reported improvements in respiratory symptoms
and eating disturbances in both children and adolescents, and in
physical functioning and body image in adolescents in response to
increases in weight for age. Although we combined CFQ scoresfor analysis and utilized more accurate and direct indicators of
nutritional status, overall our results are consistent with what they
observed in children and adolescents for eating disturbances, and
in adolescents for physical functioning and body image.
In our study population, nutritional status was stable over the
2 years of HRQOL assessment, as were the multiple dimensions
of CFQ. One growth channel changes were only observed in 16%
for height (N=4 decrease, N=11 increase) and 14% for BMI
(N=4 decrease, N=9 increase) over the 2-year study period. Our
study population of older children would of course include those
at varying stages of pubertal development and it is worthwhile to
note that age was not associated with changes in nutritional
status. Thus, although our analyses modeled changes in both
nutritional status and CFQ scores to assess longitudinal asso-
ciations, the results reflect associations found in a population with
generally stable nutritional status and stable CFQ scores. Further,
this study population was in relatively good health. Seventy-four
percent of participants exhibited normal FEV-1 values and 14%
had mild pulmonary disease (previously reported by Tluczek [5]),
and prevalence of short stature (about 12%) and underweight
(about 8%) were low, although more than half were below the
BMI goal of the 50th percentile. On an individual level, it is
possible that acute changes in nutritional status may affect other
dimensions of HRQOL not observed in this study. Overall, in
this relatively stable population, the potential to show improve-
ment in HRQOL is likely diminished [27], suggesting that the
associations that did emerge with eating disturbances, physical
functioning and body image, are important with regard to the
maintenance of adequate nutritional status.
The interpretation of CFQ scores can be challenging because
there are no definitions for poor or excellent HRQOL. Only the
respiratory symptom dimension has been evaluated for use in
clinical trials, and a change of 4 points has been recommended as
the minimal clinically important difference (MCID) [28]. In this
study, differences greater than 4 points were observed for respi-
ratory symptoms between those with low and high percentiles of
height and BMI, but were not statistically significant. To evaluate
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to also offset imbalances caused by ceiling effects, poor CFQ
scores were distinguished from normal or excellent by catego-
rizing the scores according to corresponding responses on CFQ
items. Thus, “Mostly Low” in this study corresponds to scores
b66, which reflects a combination of the two least favorable
responses to questions in a CFQ dimension, such as ‘never’ and
‘sometimes’ for frequency responses. Results showed that those
who exhibited short stature were more likely to report low scores
for eating disturbances, and those who were below the BMI goal
of being at or above the 50th percentile had a greater odds of
havingMostly Low scores for body image, consistent with results
from analysis of continuous variables. Underweight was not
associated with Mostly Low scores for any dimension.
Although not statistically significant when adjusting for other
factors, it is noteworthy that among those with short stature, the
percent with Mostly Low scores was more than twice as much
compared to the percent with Mostly Low scores who were not
short, for physical functioning (44% versus 8%) and respiratory
symptoms (34% versus 15%). A similar pattern was observed for
being below the BMI goal, whereby a doubling of the percentage
of Mostly Low scores for physical functioning and social func-
tioning was observed (16% versus 8% and 22% versus 11%,
respectively).
Evaluation of Mostly Low scores according to pancreatic
phenotype was revealing. MI subjects had a significantly greater
prevalence of Mostly Low scores for physical functioning (25%),
respiratory symptoms (32%) and treatment burden (59%). Con-
versely, for dimension scores not significantly associated with
pancreatic function phenotype, MI subjects reported a similar
prevalence of Perfect scores (all items that constitute a CFQ
dimension have best response) for eating disturbances, body
image and social functioning compared to PI and PS phenotypes.
Worse HRQOL scores in the physical and treatment domains,
combined with significantly lower HtZ scores, underscores the
greater negative impact on well-being CF has on those with MI.
In conclusion, the results presented here provide further
evidence of the importance of optimizing CF nutritional status
throughout childhood and the teenage years. This study de-
scribes the novel findings that concurrent measures of height
and BMI were positively associated with eating disturbances,
physical functioning and body image. Our finding that better
nutritional status is related to fewer issues within these domains
of well-being in a population that had high scores overall
provides rationale and support for a greater focus on the inte-
gration of measurable clinical outcomes and the enhancement
of patients’ quality of life.Acknowledgements
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